Crossmark

Optimum combined MET according to tolerability with efficacy, Silodosin Tadalafil versus Silodosin Vardenafil for distal ureteric stone: a prospective, double blinded, randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s11255-024-04147-w

Published Online: 2024-08-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Diab, Tamer https://orcid.org/0000-0002-9936-567X
Noah, Kareem

Farag, Mahmoud

Shaher, Hussein
License Information

Text and Data Mining valid from 2024-08-06

Version of Record valid from 2024-08-06
More Information

Article History

Received: 9 May 2024

Accepted: 3 July 2024

First Online: 6 August 2024

Declarations

:

: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

: The study was approved by the Research Ethics Committee, Faculty of Medicine, Benha University, Egypt (Approval code: RC 24-2-2023).

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below